secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cosmos Health Inc. (COSM)
CIK:        0001474167
Form:       8-K
Filed at:   2023-01-12T23:59:59+00:00
Accession:  0001477932-23-000211
Event type: m_and_a
Sentiment:  positive
Materiality: 0.60
Item codes: 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cosmos Health extends LOI to acquire Cana Labs; renegotiates payment terms
--------------------------------------------------------------------------

- Updated binding LOI to acquire Greek pharma company Cana Laboratories; effective until May 31, 2023.
- Acquisition price renegotiated with improved payment terms; no dollar amount disclosed.
- Cana owns a 54,000 sq ft GMP-certified production facility in Athens, Greece.
- Cana has partnerships with AstraZeneca, Merck, Medtronic, Nestle, and others.
- CEO says acquisition would vertically integrate manufacturing and expand product portfolio.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1474167/000147793223000211/0001477932-23-000211-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1474167/000147793223000211/cosm_8k.htm
  HTML page:      https://secwatch.observer/filing/0001477932-23-000211

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer